TRIM56
E3 ubiquitin-protein ligase TRIM56
Also known as: RNF109, TRI56_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BRZ2
- Gene
- TRIM56
- Ensembl
- ENSG00000169871
- Chromosome
- 7
- Canonical length
- 755 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
Enables ubiquitin protein ligase activity. Involved in defense response to virus; positive regulation of signal transduction; and protein monoubiquitination. Predicted to be located in cytoplasm. Predicted to be active in nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
755 residues, UniProt reviewed canonical sequence.
>Q9BRZ2|TRIM56
1 MVSHGSSPSL LEALSSDFLA CKICLEQLRA PKTLPCLHTY CQDCLAQLAD GGRVRCPECR
61 ETVPVPPEGV ASFKTNFFVN GLLDLVKARA CGDLRAGKPA CALCPLVGGT STGGPATARC
121 LDCADDLCQA CADGHRCTRQ THTHRVVDLV GYRAGWYDEE ARERQAAQCP QHPGEALRFL
181 CQPCSQLLCR ECRLDPHLDH PCLPLAEAVR ARRPGLEGLL AGVDNNLVEL EAARRVEKEA
241 LARLREQAAR VGTQVEEAAE GVLRALLAQK QEVLGQLRAH VEAAEEAARE RLAELEGREQ
301 VARAAAAFAR RVLSLGREAE ILSLEGAIAQ RLRQLQGCPW APGPAPCLLP QLELHPGLLD
361 KNCHLLRLSF EEQQPQKDGG KDGAGTQGGE ESQSRREDEP KTERQGGVQP QAGDGAQTPK
421 EEKAQTTREE GAQTLEEDRA QTPHEDGGPQ PHRGGRPNKK KKFKGRLKSI SREPSPALGP
481 NLDGSGLLPR PIFYCSFPTR MPGDKRSPRI TGLCPFGPRE ILVADEQNRA LKRFSLNGDY
541 KGTVPVPEGC SPCSVAALQS AVAFSASARL YLINPNGEVQ WRRALSLSQA SHAVAALPSG
601 DRVAVSVAGH VEVYNMEGSL ATRFIPGGKA SRGLRALVFL TTSPQGHFVG SDWQQNSVVI
661 CDGLGQVVGE YKGPGLHGCQ PGSVSVDKKG YIFLTLREVN KVVILDPKGS LLGDFLTAYH
721 GLEKPRVTTM VDGRYLVVSL SNGTIHIFRV RSPDSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRIM56 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 20 nTPM
Expression across tissuesHPA
Tissue
- spleen: 20 nTPM
- ovary: 17 nTPM
- lung: 17 nTPM
- blood vessel: 15 nTPM
- skin: 15 nTPM
- lymph node: 14 nTPM
Single-cell type
- leydig cells: 138 nCPM
- respiratory ciliated cells: 132 nCPM
- epididymal efferent duct ciliated cells: 117 nCPM
- basal prostatic cells: 111 nCPM
- epididymal basal cells: 108 nCPM
- lacrimal acinar cells: 107 nCPM
Immune cell
- NK-cell: 4.1 nTPM
- neutrophil: 3.9 nTPM
- gdT-cell: 1.8 nTPM
- basophil: 1.7 nTPM
- naive CD8 T-cell: 1.7 nTPM
- naive B-cell: 1.6 nTPM
Brain region
- medulla oblongata: 33 nTPM
- white matter: 32 nTPM
- thalamus: 28 nTPM
- pons: 26 nTPM
- midbrain: 26 nTPM
- basal ganglia: 26 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.9
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.25
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- defense response to virus
- innate immune response
- positive regulation of innate immune response
- positive regulation of interferon-beta production
- positive regulation of non-canonical NF-kappaB signal transduction
- positive regulation of type I interferon-mediated signaling pathway
- protein K63-linked ubiquitination
- protein monoubiquitination
- regulation of type I interferon production
- response to type I interferon
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRIM56 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRIM56 as an antibody target. Whether an autoantibody or antibody against TRIM56 could matter depends on whether native TRIM56 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRIM56 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRIM56 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...